Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Roche changing of guard: Roche Molecular Diagnostics CEO Daniel O'Day will head the Swiss firm's entire test business at year-end when current diagnostics CEO Juergen Schwiezer retires, Roche said Sept. 8. O'Day's new title will be chief operating officer, rather than CEO, of the Diagnostics Division, but like Schwiezer he will report directly to Roche CEO Severin Schwan. Under the new structure, the head of the diabetes care division, Burkhard Piper, will report to O'Day, rather than to Schwan, as Piper has been doing since 2008 when Schwan took over the company. Schwiezer took the helm of the diagnostics unit last year to replace Schwan, who previously ran the laboratory products business (1"The Gray Sheet" Oct. 8, 2007). Also as part of the changes, Pharma Division head William M. Burns will be replaced by Pascal Soriot, who has led Genentech since Roche acquired the biotech firm earlier this year
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT027913

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel